Investing.com - Patterson reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Patterson announced earnings per share of $0.32 on revenue of $1.52B. Analysts polled by Investing.com anticipated EPS of $0.3766 on revenue of $1.55B.
Patterson shares are down 37% from the beginning of the year, still down 26.07% from its 52 week high of $35.29 set on April 18. They are under-performing the Nasdaq which is down 24.67% from the start of the year.
Patterson follows other major Healthcare sector earnings this month
Patterson's report follows an earnings missed by Eli Lilly on August 4, who reported EPS of $1.25 on revenue of $6.49B, compared to forecasts EPS of $1.7 on revenue of $6.85B.
Novo Nordisk ADR had missed expectations on August 4 with second quarter EPS of $0.7976 on revenue of $5.62B, compared to forecast for EPS of $0.8198 on revenue of $5.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar